Drug Target Review: Pinpointing function in cancer T cells could be new immunotherapy
UC research has found that increasing a certain function in cancer T cells could mean a new therapy
A previously unknown T cell mechanism that could explain the reason behind decreased immune function in cancer patients has been discovered. According to University of Cincinnati researchers, their finding may present a new immunotherapeutic target for patients with head and neck cancers.
The study, led by Laura Conforti and Ameet Chimote, in the Division of Nephrology and Hypertension, UC Department of Internal Medicine, revealed that a reduced interaction between a molecule called calmodulin and the ion channel KCa3.1 in the immune cells of cancer patients plays an important role in the limited function of these cells. The team performed experiments on cytotoxic T cells taken from the blood of patients with head and neck cancer.
Featured photo courtesy of Laura Conforti and Ameet Chimote.
Related Stories
'My health is priceless'
April 7, 2026
Weight loss drugs, including Ozempic and Wegovy, are changing more than waistlines — they're quietly transforming how people spend money, what they prioritize and who can afford better health. As Local 12/WKRC-TV recently reported, for some patients, the medications are life-changing. For others, the cost can be overwhelming.
Students prefer AI chatbots, until they know it is one
April 7, 2026
A University of Cincinnati College of Nursing pilot study found that Doctor of Nursing Practice students preferred AI chatbot responses over human answers — until they suspected the source was a chatbot, revealing trust issues in higher education advising.
Photographic Poem Inventions on display in new exhibition at UC Blue Ash
April 6, 2026
A photo exhibition that explores decay, disappearance and dysfunction is currently on display at the University of Cincinnati Blue Ash College. Photographic Poem Inventions was created by H. Michael Sanders, professor emeritus of Media Communications at UC Blue Ash.